Revolution Medicines, Inc. RVMD Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s intangibles (net)?
- Revolution Medicines, Inc. (RVMD) reported intangibles (net) of $55.8M in Q1 2026.
- How has Revolution Medicines, Inc.'s intangibles (net) changed year-over-year?
- Revolution Medicines, Inc.'s intangibles (net) decreased by 1.1% year-over-year, from $56.4M to $55.8M.
- What is the long-term trend for Revolution Medicines, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s intangibles (net) has grown at a -1.7% compound annual growth rate (CAGR), from $60.95M to $55.8M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.